financetom
Business
financetom
/
Business
/
Visa gets vaccine boost as domestic spending back near pre-COVID levels
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Visa gets vaccine boost as domestic spending back near pre-COVID levels
Jul 28, 2021 1:28 AM

Visa Inc beat estimates for quarterly profit on Tuesday, with domestic spending almost back to pre-pandemic levels and international travel on the road to recovery as rising vaccinations and reopening economies take effect.

Share Market Live

NSE

Payment companies are seeing an uptick in volumes from the coronavirus-induced slump as travel and entertainment spending gathers force, while the rise of e-commerce during lockdowns also drives transactions.

Visa reported a 34 percent jump in third-quarter payment volumes on a constant dollar basis, while the number of transactions processed surged 39 percent.

"In our domestic businesses, we are pretty much back to where we were, had the pandemic never happened," Chief Financial Officer Vasant Prabhu told Reuters.

"The one area of our business that is still not back to where it was is cross-border travel. That is the next stage of recovery," he said.

Cross-border volumes jumped 47 percent on a constant currency basis in the quarter.

Travel spending volumes at Visa were approaching 2019 levels in July, while entertainment surpassed those levels in May, Prabhu told analysts on a call.

Total revenue climbed 27 percent to USD 6.13 billion. Assuming July trends continue, Visa's fourth-quarter net revenue growth is expected to be in line with the third quarter, Prabhu said.

Net income rose to USD 2.58 billion in the quarter ended June 30 from USD 2.37 billion a year earlier. On an adjusted basis, Visa reported a profit of USD 1.49 per share, compared with Refinitiv estimates of USD 1.35.

Prabhu said there was no evidence of an impact from the Delta variant of the coronavirus on people buying things in their home countries.

"Even as infections are climbing, people don't seem to be changing their habits like they were before," he said.

A recent announcement by the UK and Canada regarding border openings in August should boost the current quarter, Prabhu added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BeiGene Enters Global Licensing Agreement with CSPC Zhongqi for Experimental Cancer Therapy
BeiGene Enters Global Licensing Agreement with CSPC Zhongqi for Experimental Cancer Therapy
Dec 13, 2024
05:54 AM EST, 12/13/2024 (MT Newswires) -- BeiGene ( BGNE ) said late Thursday it has signed a global licensing agreement with CSPC Zhongqi Pharmaceutical Technology for its experimental cancer therapy, SYH2039. Under the terms of the deal, the company said it has an exclusive worldwide license to develop, manufacture and commercialize SYH2039. CSPC will receive $150 million in upfront,...
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 billion deal, sources say
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 billion deal, sources say
Dec 13, 2024
HONG KONG (Reuters) - Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan's Mitsubishi Chemical Group, in a deal that could value it at between $3 billion and $3.5 billion, three sources said. Mitsubishi Chemical has hired Goldman Sachs to run the sale process and binding bids are due...
JPMorgan Elects Hershey's Chief Executive Michele Buck to Board
JPMorgan Elects Hershey's Chief Executive Michele Buck to Board
Dec 13, 2024
05:48 AM EST, 12/13/2024 (MT Newswires) -- JPMorgan Chase ( JPM ) said Thursday it elected Hershey's (HSY) Chairman and Chief Executive Michele Buck to its board, effective March 17. Buck became Hershey's CEO in 2017. ...
Nyxoah Commercially Launches Genio Therapy in England; Shares Up Pre-Bell
Nyxoah Commercially Launches Genio Therapy in England; Shares Up Pre-Bell
Dec 13, 2024
05:45 AM EST, 12/13/2024 (MT Newswires) -- Nyxoah ( NYXH ) said Friday it commercially launched its Genio therapy for obstructive sleep apnea in England. The company said it completed its first two Genio implants at University College London Hospitals. Genio is now covered under the specialized services devices program of England's National Health Service, Nyxoah ( NYXH ) said....
Copyright 2023-2026 - www.financetom.com All Rights Reserved